Expand VTAK Menu
VTAK MENU

VTAK Latest Press Releases

-- November 14, 2024 --

Catheter Precision, Inc. Announces Initial LockeT Purchase From Montefiore Medical Center ACCESSWIRE 8:01 AM

-- November 13, 2024 --

Catheter Precision, Inc. Announces Third Quarter Update and Financial Results ACCESSWIRE 8:01 AM

-- November 4, 2024 --

Catheter Precision, Inc. Announces New Clinical Data Presented at SCRN ACCESSWIRE 8:32 AM

-- October 25, 2024 --

Catheter Precision, Inc. Announces Exercise of Warrants for $4.9 Million of Gross Proceeds ACCESSWIRE 8:31 AM

-- October 23, 2024 --

Catheter Precision to Attend Society for Cardiac Robotic Navigation With New Clinical Data Presented on October 28 29 ACCESSWIRE 8:01 AM

-- October 21, 2024 --

Catheter Precision Announces Clinical Publication of Non-Invasive Stereotactic Radioablation Using VIVO ACCESSWIRE 8:34 AM

-- October 15, 2024 --

Catheter Precision to Attend the International Symposium on Catheter Ablation Techniques ACCESSWIRE 8:32 AM

-- October 10, 2024 --

Catheter Precision Scheduled to Attend the International Ventricular Tachycardia (VT) Symposium October 11 - 12 in New York City ACCESSWIRE 8:31 AM

-- October 2, 2024 --

Catheter Precision Continues to Expand Clinical Data and Acceptance of VIVO ACCESSWIRE 8:33 AM

-- September 24, 2024 --

Catheter Precision, Inc. Receives Chinese Patent for LockeT ACCESSWIRE 8:32 AM

-- September 18, 2024 --

Catheter Precision, Inc. Expands LockeT Distribution to Middle East ACCESSWIRE 8:32 AM

-- September 11, 2024 --

Catheter Precision, Inc. (NYSE American: VTAK) Reports First Purchase Order for LockeT in the Pacific Northwest Territory ACCESSWIRE 8:32 AM

-- September 5, 2024 --

Presentation at European Society of Cardiology Demonstrates VIVO Accuracy in Complex VT Patients ACCESSWIRE 9:03 AM

-- September 4, 2024 --

Catheter Precision, Inc. (NYSE American:VTAK) Reports First Purchase Order for LockeT in a New US Territory ACCESSWIRE 8:32 AM

-- September 3, 2024 --

Catheter Precision, Inc. Announces Closing of $3.6 Million Underwritten Public Offering and Exercise of Overallotment Option ACCESSWIRE 4:18 PM

-- August 30, 2024 --

Catheter Precision, Inc. Announces Pricing of $3.1 Million Underwritten Public Offering ACCESSWIRE 9:31 AM

-- August 14, 2024 --

Catheter Precision, Inc. (NYSE American: VTAK) Reports Q2 2024 Highlights and Operational Performance Report ACCESSWIRE 8:47 AM

-- August 6, 2024 --

Catheter Precision, Inc. Announces Publication of LockeT Data in the Journal of Cardiovascular Electrophysiology ACCESSWIRE 8:02 AM

-- July 25, 2024 --

Catheter Precision, Inc. Completes Enrollment of 75 Patients in LockeT-II Study ACCESSWIRE 8:01 AM

-- July 16, 2024 --

Catheter Precision, Inc. Announces the Completion of Patient Follow-up for the VIVO European Registry and New Product Evaluations of VIVO ACCESSWIRE 8:16 AM

-- July 15, 2024 --

Catheter Precision, Inc. Announces Effectiveness of 1-for-10 Reverse Stock Split ACCESSWIRE 8:01 AM